[1] Chalasani NP, Maddur H, Russo MW, et al. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver Injury. Am J Gastroenterol, 2021, 116(5):878-898.
[2] Wu Y, Ma KL, Zhang Y, et al. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease. Liver Int,2016,36: 1525-1534.
[3] Nogueiras R, Aspichueta P. Expanding the roles of the renin-angiotensin system: drug-induced liver injury. J Hepatol, 2023,78(3):457-459.
[4] Feltenberger JD, Andrade JM, Paraiso A, et al. Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice. Hypertension, 2013, 62: 324-330.
[5] Song LN, Liu JY, Shi TT, et al. Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. FASEB J, 2020,34:16291-16306.
[6] 徐清扬, 范建高. 肾素-血管紧张素系统抑制剂治疗非酒精性脂肪性肝病的研究进展. 肝脏, 2022,27(11):1064-1066.
[7] Fernando B, Melisa D, Agustina RM, et al. Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease-a physiopatho-logical and clinical integrated view. Alimentary Pharmacology & Therapeutics, 2018,48(9):892-913.
[8] Williams JA, Ding WX . Role of autophagy in alcohol and drug-induced liver injury. Food and Chemical Toxicology, 2020,136:111075.
[9] 史琳娜, 王柯, 邓玉娣,等. 脂噬对脂质代谢的调节作用及其分子机制. 南方医科大学学报, 2019, 39(7):867-874.
[10] Czaja MJ. Function of autophagy in nonalcoholic fatty liver disease. Dig Dis Sci, 2016,61:1304-1313.
[11] Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? J Hepatol, 2017,67:1324-1331.
[12] Xiong X, Tao R, DePinho RA, et al. The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J Biol Chem, 2012,287:39107-39114.
[13] Chen S, Lu Z, Jia H, et al. Hepatocyte-specifific Mas activation enhances lipophagy and fatty acid oxidation to protect against acetaminophen-induced hepatotoxicity in mice. J Hepatol, 2023,78:543-557.
[14] Xiao H, Liu X, Wang Y, et al. Angiotensin (1-7) prevents lipopolysaccharide? induced hepatocellular inflammatory response by inhibiting the p38 MAPK/AP? 1 signaling pathway. Molecular Medicine Reports, 2018,17(4):5492-5497.
[15] de Oliveira da Silva B, Alberici LC, Ramos LF, et al. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1-7) and miRNA-1914-5p identification as regulator of profibrogenic elements and lipid metabolism. Int J Biochem Cel Biol, 2018, 98:137-155.
[16] Wen SW, Ager EI, Neo J, et al. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases. Cancer Biol Ther, 2013,14:720-727.
[17] Fu D, Wu S, Jiang X, et al. Caveolin-1 alleviates acetaminophen-induced vascular oxidative stress and inflammation in non-alcoholic fatty liver disease. Free Radical Bio Med, 2023,195:245-257.
[18] Wang C, Ren L, Chen S, et al. Longdan Xiegan Tang attenuates liver injury and hepatic insulin resistance by regulating the angiotensin-converting enzyme 2/Ang (1-7)/Mas axis-mediated anti-inflammatory pathway in rats. J Ethnopharmacol, 2021, 274: 114072.
[19] Wester A, Devocelle M, Tallant EA, et al. Stabilization of angiotensin-(1-7) by key substitution with a cyclic nonnatural amino acid. Amino Acids, 2017, 49:1733-1742.
[20] Rodgers KE, Bolton LL, Verco S, et al. NorLeu(3)-Angiotensin (1-7) [DSC127] as a therapy for the healing of diabetic foot ulcers. Adv Wound Care, 2015,4(6):339-345. |
